Singapore markets closed

aTyr Pharma, Inc. (LIFE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6400+0.0400 (+2.50%)
At close: 04:00PM EDT
1.6800 +0.04 (+2.44%)
Pre-market: 08:02AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.6000
Open1.6000
Bid1.6200 x 200
Ask1.6500 x 300
Day's range1.5750 - 1.6800
52-week range1.0800 - 2.7000
Volume293,399
Avg. volume554,937
Market cap111.423M
Beta (5Y monthly)1.23
PE ratio (TTM)N/A
EPS (TTM)-0.9400
Earnings date07 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est22.60
  • Simply Wall St.

    aTyr Pharma Insiders Placed Bullish Bets Worth US$514.6k

    It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

  • GlobeNewswire

    aTyr Pharma to Participate in April Investor Conferences

    SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in two upcoming investor conferences scheduled to take place in April 2024. Details of the conferences appear below: Conference: Evercore ISI Diamonds in the Rough Webinar DayDate: Thursday, April 4, 2024 Time: 10:3

  • Simply Wall St.

    aTyr Pharma Full Year 2023 Earnings: Revenues Disappoint

    aTyr Pharma ( NASDAQ:LIFE ) Full Year 2023 Results Key Financial Results Net loss: US$50.4m (loss widened by 11% from...